Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FA2U8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,076
Award facts
- Contract value 100% obligated
- $19,075.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,075.69 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded contract (4570544082) was issued on January 16, 2026, with an ultimate completion date of January 20, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle through December 2026 that serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare systems globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), is a major pharmaceutical distributor that supplies comprehensive medical commodities including brand-name and generic medications, vaccines, and specialty healthcare products to federal agencies. The company's parent entity, Cencora, Inc., holds the prime IDC and has demonstrated significant capability in fulfilling federal pharmaceutical procurement requirements through open competition. Repatha is a PCSK9 inhibitor indicated for cholesterol management, and this award reflects continued federal procurement of essential cardiovascular medications to support military personnel and beneficiary healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FA2U8?
SPE2DR26FA2U8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FA2U8 worth?
The government has obligated $19,076 on SPE2DR26FA2U8.
Is contract SPE2DR26FA2U8 an order under another contract?
Yes. SPE2DR26FA2U8 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2U8 competed?
The extent of competition for SPE2DR26FA2U8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award